Plain-English translation of NCT06066723 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This pilot study is testing a new imaging technique called 19F MRI that uses a special inert gas called perfluoropropane to help doctors see how air moves through children's lungs. The researchers want to know whether this imaging method works safely and effectively in children, and whether it can detect early signs of lung problems in children with cystic fibrosis who have mild or no symptoms. They'll compare results from children with cystic fibrosis to healthy children to understand what normal looks like.
Current lung function tests don't always catch early, subtle lung changes in cystic fibrosis. This new imaging technique could provide clearer pictures of how air moves through the lungs and might help doctors spot problems earlier, before they become serious, so children can get help sooner.
You likely qualify if…
You likely don't qualify if…
If you qualify, you'll visit the research center and undergo MRI scans while breathing in the special inert gas through a mask. You'll perform standard breathing tests (spirometry) and a nitrogen washout test to measure how your lungs function. The MRI part involves breathing the gas for five breath-hold cycles, and researchers will also try a newer 'free-breathing' technique that doesn't require you to hold your breath. The whole visit will likely take a few hours, and you won't need to come back for follow-up visits—this is a one-time study.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
United States